2-Month Metformin Weight Loss Results: What the Evidence Shows
An eight-week trial offers a useful reference, but no single weight-loss number predicts your own result.
Metformin may cause modest weight loss for some people, but there is no reliable number of pounds to expect after exactly two months. In one small eight-week trial, BMI fell 4.5% with metformin plus a low-calorie diet and 2.6% with placebo plus the same diet. These are group averages from 36 women who completed the study, not a personal forecast. Read the trial.
What the eight-week study actually found
Women with obesity and without diabetes; 46 were randomized.
The difference cannot be described as a metformin-only result.
The study reported percentage change in BMI, not typical pounds lost.
−4.5%
−2.6%
Small trial; both groups followed the diet. Bars show BMI change, not guaranteed weight loss. Source.
Why your result may differ
Reason for treatment
Metformin is approved to improve blood sugar in type 2 diabetes. Weight loss is not its labeled indication. U.S. label.
Food and activity
The eight-week trial included a diet in both arms. The longer Diabetes Prevention Program found a larger average weight change with intensive lifestyle support than with metformin. NIDDK.
Tolerability and time
Digestive effects can affect whether people continue treatment. Clinicians often adjust metformin gradually. MedlinePlus.
Individual response
A trial average includes people who lost more, less, or no weight. A scale reading alone does not show whether diabetes treatment is working.
A 2024 analysis of 49 randomized trials found a modest average BMI reduction with metformin in adults without diabetes, but its studies lasted at least three months. It cannot be used as a two-month prediction. Meta-analysis.
No weight loss after two months?
That can happen. Do not raise a dose or stop prescribed metformin because of the scale alone. Ask the prescriber to review the treatment goal, glucose results, kidney function, side effects and other medicines. Diabetes control and weight change are different outcomes. Metformin guidance.
Nausea and diarrhea are common. The U.S. label warns about rare but serious lactic acidosis and contraindicates metformin when eGFR is below 30 mL/min/1.73 m². Seek urgent care for severe weakness with trouble breathing or other concerning symptoms. Discuss kidney function and longer-term vitamin B12 monitoring with a clinician. U.S. label.
Questions people ask
How many pounds can I lose in two months?
There is no well-supported number for everyone. The directly relevant small trial reported percentage BMI change, not a general pounds-lost expectation.
Is metformin approved for weight loss?
No. Its U.S. indication is blood-sugar control in type 2 diabetes. A clinician may make an individualized off-label decision. See the label.
What if stomach effects make it hard to continue?
Contact the prescriber. Taking it with food, slower dose increases or an extended-release formulation may be worth discussing; do not change the prescription yourself. MedlinePlus.
General information, not medical advice. Sources reviewed October 3, 2026. If your goal or treatment is changing, see our guide to metformin alternatives and discuss options with a licensed clinician.
References
TirzaSema Editorial Team
Research and editorial team
The TirzaSema Editorial Team researches U.S. GLP-1 prices and telehealth programs using official manufacturer, FDA and provider sources. Every review states whether it is based on hands-on testing or on research of public information,…
Keep reading
Enter your weight to convert the NIH sports-nutrition range to daily grams, with safeguards and clear limits.
A clear, source-linked guide to Ozempic pen and pill directions, including the different missed-dose rules.
The right alternative depends on why you take metformin. Compare options by treatment goal and discuss a plan with your clinician.